Related references
Note: Only part of the references are listed.Effect of optogenetic modulation on entopeduncular input affects thalamic discharge and behavior in an AAV2-α-synuclein-induced hemiparkinson rat model
Hyeong Cheol Moon et al.
NEUROSCIENCE LETTERS (2018)
Leucine-rich repeat kinase 2 and Parkinson's disease
Un-Beom Kang et al.
PROTEOMICS (2017)
Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats
Fei Hao et al.
EXPERIMENTAL NEUROLOGY (2017)
Exploring the potential of genome editing CRISPR-Cas9 technology
Vijai Singh et al.
GENE (2017)
Regulation of human GDNF gene expression in nigral dopaminergic neurons using a new doxycycline-regulated NTS-polyplex nanoparticle system
Armando J. Espadas-Alvarez et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Intracerebral injections of DNA nanoparticles encoding for a therapeutic gene provide partial neuroprotection in an animal model of neurodegeneration
David Yurek et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential
Maria Lindahl et al.
NEUROBIOLOGY OF DISEASE (2017)
Early Insights from Commercialization of Gene Therapies in Europe
Nicolas Touchot et al.
GENES (2017)
Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease
Yoshihide Sehara et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2017)
Chemogenetic Modulation of G Protein-Coupled Receptor Signalling in Visual Attention Research
Soren H. Jorgensen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinon's Disease (PD)
Muhammad Abid Sheikh et al.
ACTA BIOMATERIALIA (2017)
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease
Martin Niethammer et al.
JCI INSIGHT (2017)
The genetic background of Parkinson's disease: current progress and future prospects
K. Kalinderi et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Optogenetic Approaches for Controlling Seizure Activity
Jack K. Tung et al.
BRAIN STIMULATION (2016)
Nurr1-Based Therapies for Parkinson's Disease
Jie Dong et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
Surgical Treatment of Parkinson's Disease
Leo Verhagen Metman et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease (vol 7, pg 510, 2015)
Sang-Min Oh et al.
EMBO MOLECULAR MEDICINE (2016)
Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces -Synuclein Aggregation
Jordan Follett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects
Toshiharu Nagatsu et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Teaching neurons to respond to placebos
Fabrizio Benedetti et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
Joana Duarte-Neves et al.
NEUROBIOLOGY OF DISEASE (2016)
Optogenetic stimulation of cortico-subthalamic projections is sufficient to ameliorate bradykinesia in 6-ohda lesioned mice
Teresa H. Sanders et al.
NEUROBIOLOGY OF DISEASE (2016)
Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease
Pia Runeberg-Roos et al.
NEUROBIOLOGY OF DISEASE (2016)
Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease
Arun Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease
Hyung Ho Yoon et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2016)
Spinal Plasticity and Behavior: BDNF-Induced Neuromodulation in Uninjured and Injured Spinal Cord
Sandra M. Garraway et al.
NEURAL PLASTICITY (2016)
CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
Weili Yang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
C. Warren Olanow et al.
ANNALS OF NEUROLOGY (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease
Ilse S. Pienaar et al.
MOLECULAR NEURODEGENERATION (2015)
Enhanced Efficacy of the CDNF/MANF Family by Combined Intranigral Overexpression in the 6-OHDA Rat Model of Parkinson's Disease
Oscar Cordero-Llana et al.
MOLECULAR THERAPY (2015)
Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
R. T. Bartus et al.
NEUROBIOLOGY OF DISEASE (2015)
Role of two sequence motifs of mesencephalic astrocyte-derived neurotrophic factor in its survival-promoting activity
K. Matlik et al.
CELL DEATH & DISEASE (2015)
An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease
Ilse S. Pienaar et al.
BRAIN STRUCTURE & FUNCTION (2015)
The Medical Treatment of Parkinson Disease from James Parkinson to George Cotzias
Stanley Fahn
MOVEMENT DISORDERS (2015)
DNAJC13 Genetic Variants in Parkinsonism
Emil K. Gustavsson et al.
MOVEMENT DISORDERS (2015)
Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease
Nancy G. Hernandez-Chan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Transgenic Expression of Human Glial Cell Line-Derived Neurotrophic Factor from Integration-Deficient Lentiviral Vectors is Neuroprotective in a Rodent Model of Parkinson's Disease
Ngoc B. Lu-Nguyen et al.
HUMAN GENE THERAPY (2014)
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
Stephane Palfi et al.
LANCET (2014)
Noninvasive optical inhibition with a red-shifted microbial rhodopsin
Amy S. Chuong et al.
NATURE NEUROSCIENCE (2014)
Optogenetic Inactivation of the Subthalamic Nucleus Improves Forelimb Akinesia in a Rat Model of Parkinson Disease
Hyung Ho Yoon et al.
NEUROSURGERY (2014)
Titer and Product Affect the Distribution of Gene Expression after Intraputaminal Convection-Enhanced Delivery
Marina E. Emborg et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2014)
The impact of the endoplasmic reticulum protein-folding environment on cancer development
Miao Wang et al.
NATURE REVIEWS CANCER (2014)
Cardiac optogenetics
Emilia Entcheva
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases
Ping Wu et al.
BRAIN RESEARCH BULLETIN (2013)
Glial Cell Line-Derived Neurotrophic Factor Partially Ameliorates Motor Symptoms Without Slowing Neurodegeneration in Mice With Respiratory Chain-Deficient Dopamine Neurons
Fredrik H. Sterky et al.
CELL TRANSPLANTATION (2013)
Simvastatin Induces Neuroprotection in 6-OHDA-Lesioned PC12 via the PI3K/AKT/Caspase 3 Pathway and Anti-Inflammatory Responses
Yun-Qi Xu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model
Xinmiao Ren et al.
EXPERIMENTAL NEUROLOGY (2013)
Control of Basal Ganglia Output by Direct and Indirect Pathway Projection Neurons
Benjamin S. Freeze et al.
JOURNAL OF NEUROSCIENCE (2013)
NRSF/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP
Mei Yu et al.
NEUROBIOLOGY OF AGING (2013)
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
Raymond T. Bartus et al.
NEUROLOGY (2013)
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity
Mickael Decressac et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An ERcentric view of Parkinson's disease
Gabriela Mercado et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Novel designer receptors to probe GPCR signaling and physiology
Juergen Wess et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
Susanne Back et al.
BRAIN AND BEHAVIOR (2013)
Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease
M. Decressac et al.
EXPERIMENTAL NEUROLOGY (2012)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
Mesencephalic Astrocyte-derived Neurotrophic Factor Protects the Heart from Ischemic Damage and Is Selectively Secreted upon Sarco/endoplasmic Reticulum Calcium Depletion
Christopher C. Glembotski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's Disease
Erik Cederfjall et al.
MOLECULAR THERAPY (2012)
NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease
Daniel Martinez-Fong et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease
Mickael Decressac et al.
NEUROBIOLOGY OF AGING (2012)
Viral vectors for gene delivery to the central nervous system
Thomas B. Lentz et al.
NEUROBIOLOGY OF DISEASE (2012)
Multifaces of neuropeptide Y in the brain - Neuroprotection, neurogenesis and neuroinflammation
J. O. Malva et al.
NEUROPEPTIDES (2012)
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease
Mickael Decressac et al.
BRAIN (2011)
Signaling of Glial Cell Line-Derived Neurotrophic Factor and Its Receptor GFRα1 Induce Nurr1 and Pitx3 to Promote Survival of Grafted Midbrain-Derived Neural Stem Cells in a Rat Model of Parkinson Disease
Zhinian Lei et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A. LeWitt et al.
LANCET NEUROLOGY (2011)
Bioactivity of AAV2-Neurturin Gene Therapy (CERE-120): Differences Between Parkinson's Disease and Nonhuman Primate Brains
Raymond T. Bartus et al.
MOVEMENT DISORDERS (2011)
An optogenetic toolbox designed for primates
Ilka Diester et al.
NATURE NEUROSCIENCE (2011)
Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
Raymond T. Bartus et al.
NEUROBIOLOGY OF DISEASE (2011)
The TrkB-Positive Dopaminergic Neurons are Less Sensitive to MPTP Insult in the Substantia Nigra of Adult C57/BL Mice
Yin-Xiu Ding et al.
NEUROCHEMICAL RESEARCH (2011)
TFEB Links Autophagy to Lysosomal Biogenesis
Carmine Settembre et al.
SCIENCE (2011)
The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson's Disease
Torsten Falk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
Adrian P. Kells et al.
JOURNAL OF NEUROSCIENCE (2010)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
William J. Marks et al.
LANCET NEUROLOGY (2010)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
Shin-ichi Muramatsu et al.
MOLECULAR THERAPY (2010)
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
Alexxai V. Kravitz et al.
NATURE (2010)
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Lara Lourenco Venda et al.
TRENDS IN NEUROSCIENCES (2010)
Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer
M. Hedman et al.
GENE THERAPY (2009)
Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
Jamie L. Eberling et al.
HUMAN GENE THERAPY (2009)
Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
Louisa C. Johnston et al.
HUMAN GENE THERAPY (2009)
Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
Xiaomin Su et al.
HUMAN GENE THERAPY (2009)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
Optical Deconstruction of Parkinsonian Neural Circuitry
Viviana Gradinaru et al.
SCIENCE (2009)
Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
Bechir Jarraya et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Armet, a UPR-upregulated protelin, inhibits cell proliferation and ER stress-induced cell death
Andria Apostolou et al.
EXPERIMENTAL CELL RESEARCH (2008)
MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector
Yuan-Hao Chen et al.
FASEB JOURNAL (2008)
Decreased NURR1 gene expression in patients with Parkinson's disease
Weidong Le et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
William J. Marks et al.
LANCET NEUROLOGY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum
Christopher D. Herzog et al.
MOLECULAR THERAPY (2008)
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Jose A. Obeso et al.
MOVEMENT DISORDERS (2008)
Engineering GPCR signaling pathways with RASSLs
Bruce R. Conklin et al.
NATURE METHODS (2008)
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
J. L. Eberling et al.
NEUROLOGY (2008)
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease
Andrew Feigin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo
Pivi Lindholm et al.
NATURE (2007)
AAV2 - mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson's disease
Mehdi Gasmi et al.
NEUROBIOLOGY OF DISEASE (2007)
Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors
You-yong Tian et al.
NEUROSCIENCE LETTERS (2007)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys
Christopher D. Herzog et al.
MOVEMENT DISORDERS (2007)
Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism
Marina E. Emborg et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease
Mehdi Gasmi et al.
MOLECULAR THERAPY (2007)
Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys
Jeffrey H. Kordower et al.
ANNALS OF NEUROLOGY (2006)
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
Krystof S. Bankiewicz et al.
MOLECULAR THERAPY (2006)
A dose-ranging study of AAV-hAADC therapy in parkinsonian monkeys
John R. Forsayeth et al.
MOLECULAR THERAPY (2006)
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
A Schrag et al.
LANCET NEUROLOGY (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys
MM Daadi et al.
NEUROREPORT (2006)
Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration
WY Lee et al.
EXPERIMENTAL NEUROLOGY (2006)
Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats
LM Sanftner et al.
MOLECULAR THERAPY (2006)
Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease
XG Li et al.
MOLECULAR THERAPY (2006)
The DnaJ-domain protein RME-8 functions in endosomal trafficking
M Girard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease
M Sun et al.
BRAIN RESEARCH (2005)
Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models
B Lee et al.
GENE THERAPY (2005)
The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model
T Yasuhara et al.
BRAIN RESEARCH (2005)
Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons
MJ Porritt et al.
EXPERIMENTAL NEUROLOGY (2005)
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor
JT Slevin et al.
JOURNAL OF NEUROSURGERY (2005)
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study
NK Patel et al.
ANNALS OF NEUROLOGY (2005)
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease
J Jankovic et al.
PROGRESS IN NEUROBIOLOGY (2005)
Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease
T Yasuhara et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The vesicular amine transporter family (SLC18):: amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine
LE Eiden et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation
X Drouot' et al.
NEURON (2004)
Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease
M Sun et al.
HUMAN GENE THERAPY (2004)
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)
A Eslamboli et al.
EXPERIMENTAL NEUROLOGY (2003)
Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects
Y Ai et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
MANF - A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons
PS Petrova et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector
M Sun et al.
HUMAN GENE THERAPY (2003)
Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes
MM Berglund et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease
C Cannizzaro et al.
MOLECULAR BRAIN RESEARCH (2003)
Subthalamic GAD gene therapy in a Parkinson's disease rat model
J Luo et al.
SCIENCE (2002)
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
R Grondin et al.
BRAIN (2002)
Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys
N Maswood et al.
NEUROBIOLOGY OF AGING (2002)
Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease
Y Oiwa et al.
BRAIN RESEARCH (2002)
Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration
S Palfi et al.
JOURNAL OF NEUROSCIENCE (2002)
The GDNF family: Signalling, biological functions and therapeutic value
MS Airaksinen et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Parkinson-like neurodegeneration induced by targeted overexpression of α-synuclein in the nigrostriatal system
D Kirik et al.
JOURNAL OF NEUROSCIENCE (2002)
Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes
SI Muramatsu et al.
HUMAN GENE THERAPY (2002)
Effects of transient focal inactivation of the basal ganglia in parkinsonian primates
MS Baron et al.
JOURNAL OF NEUROSCIENCE (2002)
The neuropilins: Multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis
G Neufeld et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats
R Sánchez-Pernaute et al.
MOLECULAR THERAPY (2001)
Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus
V Pencea et al.
JOURNAL OF NEUROSCIENCE (2001)
Trk receptors: mediators of neurotrophin action
A Patapoutian et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Quantitative analysis of transgene protein, mRNA, and vector DNA following injection of an adenoviral vector harboring glial cell line-derived neurotrophic factor into the primate caudate nucleus
DA Kozlowski et al.
MOLECULAR THERAPY (2001)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease
Y Shen et al.
HUMAN GENE THERAPY (2000)
Convection-enhanced delivery of AAV vector in parkinsonian monkeys;: In vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach
KS Bankiewicz et al.
EXPERIMENTAL NEUROLOGY (2000)
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
